Anteris Technologies Global Corp. (AVR) vs Olema Pharmaceuticals, Inc. (OLMA)
A side-by-side comparison of Anteris Technologies Global Corp. and Olema Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVR
Anteris Technologies Global Corp.
$7.08HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
OLMA
Olema Pharmaceuticals, Inc.
$7.92HealthcareDelayed quote: Oct 6, 2026, 3:30 PM EDT
Total return — AVR vs OLMA
growth of $100 · dividends reinvested · last 2yAVR +34.8% (+16.1%/yr)OLMA +22.2% (+10.6%/yr)AVR compounded faster over this window
AVR OLMA
AVR vs OLMA: by the numbers
- •OLMA is the larger company ($691M vs $689M market cap).
- •Both run net losses; OLMA's is the smaller (0.00% vs -4619.67% net margin).
Metrics side by side
Valuation
| Metric | AVR | OLMA |
|---|---|---|
| P/S ratio | 307.20 | N/A |
| P/B ratio | 2.74 | 1.61 |
Profitability
| Metric | AVR | OLMA |
|---|---|---|
| Gross margin | -16.57% | 0.00% |
| Operating margin | -4908.21% | 0.00% |
| Net margin | -4619.67% | 0.00% |
| ROE | -41.20% | -47.51% |
| ROIC | -41.63% | -50.92% |
Growth (annualized)
| Metric | AVR | OLMA |
|---|---|---|
| Revenue CAGR (5Y) | -18.92% | N/A |
| Total return CAGR (5Y) | N/A | -21.50% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.